2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor- and neuroprotector of brain in closed head injury

1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditio...

Full description

Saved in:
Bibliographic Details
Main Authors Mechoulam, Raphael, Gallily, Ruth, Breuer, Aviva, Shohami, Esther, Panikashvili, David
Format Patent
LanguageEnglish
Published 20.05.2003
Online AccessGet full text

Cover

Loading…
Abstract 1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditions caused by TNF- and/or by radical oxgen intermediates (ROI), in pharmaceutical composition for the same use comprising as active ingredient 2-AG, the use of 2-AG and pharmaceutical compositions comprising same in the preparation of a medicament for the treatment of said indications and methods of treatment by 2-AG and pharmaceutical compositions comprising same for diseases caused by said indications. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditions caused by TNF- and/or by radical oxygen intermediates (ROI), in pharmaceutical composition for the same use comprising as active ingredient 2-AG. It comprises also the use of 2-AG and pharmaceutical compositions comprising same in the preparation of a medicament for the treatment of said indications and methods of treatment by 2-AG and pharmaceutical compositions comprising same for diseases caused by said indications.
AbstractList 1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditions caused by TNF- and/or by radical oxgen intermediates (ROI), in pharmaceutical composition for the same use comprising as active ingredient 2-AG, the use of 2-AG and pharmaceutical compositions comprising same in the preparation of a medicament for the treatment of said indications and methods of treatment by 2-AG and pharmaceutical compositions comprising same for diseases caused by said indications. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused by closed head injury, in the reduction of neurological deficits caused by closed head injury and stroke and in treating pathological conditions caused by TNF- and/or by radical oxygen intermediates (ROI), in pharmaceutical composition for the same use comprising as active ingredient 2-AG. It comprises also the use of 2-AG and pharmaceutical compositions comprising same in the preparation of a medicament for the treatment of said indications and methods of treatment by 2-AG and pharmaceutical compositions comprising same for diseases caused by said indications.
Author Panikashvili, David
Breuer, Aviva
Gallily, Ruth
Shohami, Esther
Mechoulam, Raphael
Author_xml – sequence: 1
  fullname: Mechoulam, Raphael
– sequence: 2
  fullname: Gallily, Ruth
– sequence: 3
  fullname: Breuer, Aviva
– sequence: 4
  fullname: Shohami, Esther
– sequence: 5
  fullname: Panikashvili, David
BookMark eNqNizkOwjAQRVNAwXaHKaGwhAJJjxDLAejRxJ4kRsYTje0it8eRcgCqv72_LhaePa2KVCoU1L017EfXuVGTsIN9qS6Pg0IP1ve2sZEFuIWYvtl40sLBBmhR50EBepPLJDwIR9Iz3Aja6Q_acSADPaHJ8ZNk3BbLFl2g3aybAu631_WpUhgwko_h3QlOcqyruq7Op9MfyA8uVEbZ
ContentType Patent
CorporateAuthor Yissum Research Development Company of The Hebrew University of Jerusalem
CorporateAuthor_xml – name: Yissum Research Development Company of The Hebrew University of Jerusalem
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 06566543
GroupedDBID EFH
ID FETCH-uspatents_grants_065665433
IEDL.DBID EFH
IngestDate Sun Mar 05 22:30:37 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_065665433
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6566543
ParticipantIDs uspatents_grants_06566543
PatentNumber 6566543
PublicationCentury 2000
PublicationDate 20030520
PublicationDateYYYYMMDD 2003-05-20
PublicationDate_xml – month: 05
  year: 2003
  text: 20030520
  day: 20
PublicationDecade 2000
PublicationYear 2003
References (0505817) 19920900
(9951560) 19991000
German et al. (5456912) 19951000
Di Marzo, V. et al: Cannabimimetic Fatty Acid Derivatives in Cancer and Inflammation; Prostaglandins and Other Lipid Mediators, vol. 61, Nos. 1-2, pp. 43-61, XP004197447.
Sinor, A.D. et al.: "Endocannabinoids Protect Cerebral Cortical Neurons From In Vitro Ischemia in Rats"; Neuroscience Letters, vol. 278, No. 3, Jan. 14, 2000; pp. 157-160, XP002205898.
References_xml – year: 19991000
  ident: 9951560
– year: 19951000
  ident: 5456912
  contributor:
    fullname: German et al.
– year: 19920900
  ident: 0505817
Score 2.5670104
Snippet 1. The present invention relates to 2-arachidonylglycerol (2-AG) to be used as inhibitor of a tumor necrosis factor (TNF- ), in the reduction of edema caused...
SourceID uspatents
SourceType Open Access Repository
Title 2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor- and neuroprotector of brain in closed head injury
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6566543
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH9sQ1BPioqbH-TgQQ_Rrk3X7iiyWQRlB4XdRtOXbpUuGf1A_O99acfword885LwPgK__B7ADZLTG_oUuXmpJdWOZcjD8UjxscAAcYiBn9i_w69vo-hDvMz9eQei3V-YNakR35As5X1dbirTgCvJvLcXz1vyZ8sRqC37wJfOTYwzTB9sXOILrwvd0LHQrsk0OoR9WoJCNl2Vv5zG9Aj2Zk3rMXSUPoHa5ZYbeZWhBYMv8-9EFSZnty5_fL7jsWaZXmWSFKxgJmVVvaaCVtaLZSVr0-JwRu9-1lBQbvkV2sHS5nmg-SzJTamQkYFFqn7SeZ0Cm07enyK-k3GxLCz2ZeFs9-KdQU8brc6BpYEnpcJUqkAIkWAs0iSWqGKBrhPKpA_9P5cZ_NN3AQcNOs3xSV0uoVcVtboiL1vJ6-YIfwCBbYuM
link.rule.ids 230,309,786,808,891,64396
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwEB2VglhOIECU1QcOcDC0jdOkRwQNYat6AKm3Ks44bVDqVFmE-HvGSVVxgZt3eRu_sTTzBuASCfQ6NmluVmRItQPpcrffU7wv0EHsoGOHxnf4bdjzP8Tz2B43wF_5wsxJjPiC5pLflPmiSCvjSnre64PnNfmz4QjUhn3gSydpgCOMbo1eYgtrDdYNxpq7PvD8HdiiQUhp00X-Cza8XdgYVaV70FB6H8ouN-zIsxiNOfg0-Q5VlibsqsvvHq95oFmsZ7EkEctYGrGinFNCK4Njcc7qwDic0c-fVSSUS4aFurE0kR6oPwuTNFfI6IlFyn7Sjh0A8wbv9z5fzXEyzYz1y6S9XI11CE2danUELHIsKRVGUjlCiBADEYWBRBUI7LZdGbag9ecwx__UXcDm6MGbvD4NX05guzJVa9skO6fQLLJSnRHkFvK82s0fe6-OiA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-arachidonylglycerol+%282-AG%29-an+inhibitor+of+tumor+necrosis+factor-+and+neuroprotector+of+brain+in+closed+head+injury&rft.inventor=Mechoulam%2C+Raphael&rft.inventor=Gallily%2C+Ruth&rft.inventor=Breuer%2C+Aviva&rft.inventor=Shohami%2C+Esther&rft.inventor=Panikashvili%2C+David&rft.number=6566543&rft.date=2003-05-20&rft.externalDBID=n%2Fa&rft.externalDocID=06566543